These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30963541)

  • 1. Mucosal vaccines and technology.
    Miquel-Clopés A; Bentley EG; Stewart JP; Carding SR
    Clin Exp Immunol; 2019 May; 196(2):205-214. PubMed ID: 30963541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in mucosal vaccine development: potential and limitations.
    Lycke N
    Nat Rev Immunol; 2012 Jul; 12(8):592-605. PubMed ID: 22828912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccines: recent progress in understanding the natural barriers.
    Borges O; Lebre F; Bento D; Borchard G; Junginger HE
    Pharm Res; 2010 Feb; 27(2):211-23. PubMed ID: 19953309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern mucosal vaccines, adjuvants and microbicides.
    Cranage MP; Manoussaka M
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):21-3. PubMed ID: 19622054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Strategies for Mucosal Vaccination.
    Longet S; Lundahl MLE; Lavelle EC
    Bioconjug Chem; 2018 Mar; 29(3):613-623. PubMed ID: 29300463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of oral vaccines].
    Matsubara A; Shimizu Y; Karamatsu K; Yasutomi Y
    Nihon Rinsho; 2008 Oct; 66(10):1873-8. PubMed ID: 18939484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery strategies to enhance mucosal vaccination.
    Chadwick S; Kriegel C; Amiji M
    Expert Opin Biol Ther; 2009 Apr; 9(4):427-40. PubMed ID: 19344280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of local antibody production: parenteral or mucosal vaccination?
    Bouvet JP; Decroix N; Pamonsinlapatham P
    Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizon of mucosal immunity and vaccines.
    Takahashi I; Nochi T; Yuki Y; Kiyono H
    Curr Opin Immunol; 2009 Jun; 21(3):352-8. PubMed ID: 19493665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal vaccines: Strategies and challenges.
    Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
    Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive and mucoadhesive delivery systems of mucosal vaccines.
    Han IK; Kim YB; Kang HS; Sul D; Jung WW; Cho HJ; Oh YK
    Methods; 2006 Feb; 38(2):106-11. PubMed ID: 16414271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens.
    Gosselin EJ; Bitsaktsis C; Li Y; Iglesias BV
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):311-23. PubMed ID: 19688186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccination--an old but still vital strategy.
    Długońska H; Grzybowski M
    Ann Parasitol; 2012; 58(1):1-8. PubMed ID: 23094329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunisation: adjuvants and delivery systems.
    Moyle PM; McGeary RP; Blanchfield JT; Toth I
    Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against mucosal infections.
    Holmgren J; Svennerholm AM
    Curr Opin Immunol; 2012 Jun; 24(3):343-53. PubMed ID: 22580196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.